Protein-Ligand Interactions: Target Identification and Drug Discovery

Bioactive compounds and drugs are designed and screened on the basis of specific molecular targets as well as via the identification of active ingredients from traditional medicine or by serendipitous discovery. The development of novel therapeutic strategies not only requires a deep knowledge of th...

Full description

Saved in:
Bibliographic Details
Other Authors: Altieri, Fabio (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_76609
005 20220111
003 oapen
006 m o d
007 cr|mn|---annan
008 20220111s2021 xx |||||o ||| 0|eng d
020 |a books978-3-0365-1051-4 
020 |a 9783036510507 
020 |a 9783036510514 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-1051-4  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PN  |2 bicssc 
100 1 |a Altieri, Fabio  |4 edt 
700 1 |a Altieri, Fabio  |4 oth 
245 1 0 |a Protein-Ligand Interactions: Target Identification and Drug Discovery 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (184 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Bioactive compounds and drugs are designed and screened on the basis of specific molecular targets as well as via the identification of active ingredients from traditional medicine or by serendipitous discovery. The development of novel therapeutic strategies not only requires a deep knowledge of the molecular processes and the cellular pathways involved in each pathological condition and disease, but also the specific protein targets and the effects of drug binding on protein conformation and activity. Understanding of how drugs can modify and modulate specific cellular pathways and functions will be helpful during the process of drug development and clinical trials. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Chemistry  |2 bicssc 
653 |a serum half-life extension 
653 |a fatty acid conjugation 
653 |a FcRn-mediated recycling 
653 |a serum albumin 
653 |a translocator protein (TSPO) 
653 |a CoCl2 
653 |a mitochondrial membrane potential 
653 |a reactive oxygen species (ROS) 
653 |a cell viability 
653 |a cell death 
653 |a lung cancer cell line 
653 |a acetylcholinesterase 
653 |a amyloid beta aggregation 
653 |a neuroprotection 
653 |a molecular docking 
653 |a multi-target drug 
653 |a structure-activity relationship 
653 |a brassicasterol 
653 |a phytosterols 
653 |a HSV 
653 |a Mycobacterium tuberculosis 
653 |a HSV-1 DNA polymerase 
653 |a HSV-1 TK 
653 |a human CDK2 
653 |a ACE 
653 |a UDP-galactopyranose mutase 
653 |a heat shock protein 70 
653 |a Hsp70 
653 |a piperine 
653 |a fluorescence spectroscopy 
653 |a molecular dynamics 
653 |a molecular biophysics 
653 |a GADD45β 
653 |a MKK7 
653 |a multiple myeloma 
653 |a protein-ligand interaction 
653 |a STD-NMR 
653 |a sigma receptors 
653 |a sigma ligands 
653 |a cancer 
653 |a SIGMAR1 
653 |a PGRMC1 
653 |a TMEM97 
653 |a NCI60 COMPARE analysis 
653 |a membrane 
653 |a lipid-protein interaction 
653 |a lipid signalling 
653 |a kinase regulation 
653 |a phosphatidylinositols 
653 |a molecular docking simulation 
653 |a target identification 
653 |a small-molecule derivatives of salicylanilide 
653 |a drug discovery 
653 |a drug development 
653 |a thyroid diseases 
653 |a endocrine disruptor compound 
653 |a human umbilical artery 
653 |a vascular homeostasis 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/4054  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/76609  |7 0  |z DOAB: description of the publication